87 related articles for article (PubMed ID: 28024469)
1. [Role of Non-classical NF-κB Signaling Pathway in B Acute Lymphoblastic Leukemia].
Liu XL; Cai Y; Li BJ; Huang WB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1639-1643. PubMed ID: 28024469
[TBL] [Abstract][Full Text] [Related]
2. [Function of alternative NF-κB activity in B-cell chronic lymphocytic leukemia cells].
Xu J; Zhou P; Guo F
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):40-5. PubMed ID: 24602731
[TBL] [Abstract][Full Text] [Related]
3. The role of NF-kappaB as a survival factor in environmental chemical-induced pre-B cell apoptosis.
Mann KK; Doerre S; Schlezinger JJ; Sherr DH; Quadri S
Mol Pharmacol; 2001 Feb; 59(2):302-9. PubMed ID: 11160867
[TBL] [Abstract][Full Text] [Related]
4. [Comparison and analysis between CLL-hBMSC and N-hBMSC].
Wang H; Zhou J; Xu JJ; Guo F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):914-9. PubMed ID: 25130803
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
6. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.
Liptay S; Weber CK; Ludwig L; Wagner M; Adler G; Schmid RM
Int J Cancer; 2003 Jul; 105(6):735-46. PubMed ID: 12767057
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of epimedium flavonoids in regulating immuno-senescence via nuclear factor-kappa B related signal transduction pathway].
Liu XY; Shen ZY; Huang JH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jul; 26(7):620-4. PubMed ID: 16983917
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.
Yeo AT; Chennamadhavuni S; Whitty A; Porco JA; Gilmore TD
Molecules; 2015 Apr; 20(5):7474-94. PubMed ID: 25915462
[TBL] [Abstract][Full Text] [Related]
9. Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period.
Savlı H; Akkoyunlu RU; Çine N; Gluzman DF; Zavelevich MP; Sklyarenko LM; Koval SV; Sünnetçi D
Turk J Haematol; 2016 Mar; 33(1):8-14. PubMed ID: 25912249
[TBL] [Abstract][Full Text] [Related]
10. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
[TBL] [Abstract][Full Text] [Related]
11. [Expression of NF-kappa B in human bladder cancer and its clinical significance].
Xie DH; Tang XD; Xia SJ; Tan JM; Wang XH; Cai Y
Ai Zheng; 2002 Jun; 21(6):663-7. PubMed ID: 12452071
[TBL] [Abstract][Full Text] [Related]
12. Germline configuration of nfkb2, c-rel and bcl3 in childhood acute lymphoblastic leukemia (ALL).
Liptay S; Seriu T; Bartram CR; Schmid RM
Leukemia; 1997 Aug; 11(8):1364-6. PubMed ID: 9264393
[TBL] [Abstract][Full Text] [Related]
13. The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target.
Hewamana S; Alghazal S; Lin TT; Clement M; Jenkins C; Guzman ML; Jordan CT; Neelakantan S; Crooks PA; Burnett AK; Pratt G; Fegan C; Rowntree C; Brennan P; Pepper C
Blood; 2008 May; 111(9):4681-9. PubMed ID: 18227347
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.
Wu M; Lee H; Bellas RE; Schauer SL; Arsura M; Katz D; FitzGerald MJ; Rothstein TL; Sherr DH; Sonenshein GE
EMBO J; 1996 Sep; 15(17):4682-90. PubMed ID: 8887559
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors.
Turco MC; Romano MF; Petrella A; Bisogni R; Tassone P; Venuta S
Leukemia; 2004 Jan; 18(1):11-7. PubMed ID: 14574329
[TBL] [Abstract][Full Text] [Related]
16. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
17. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors.
Bash J; Zong WX; Banga S; Rivera A; Ballard DW; Ron Y; Gélinas C
EMBO J; 1999 May; 18(10):2803-11. PubMed ID: 10329626
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
19. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.
Beg AA; Baldwin AS
Oncogene; 1994 May; 9(5):1487-92. PubMed ID: 8152812
[TBL] [Abstract][Full Text] [Related]
20. New uracil analog U-332 is an inhibitor of NF-κB in 5-fluorouracil-resistant human leukemia HL-60 cell line.
Długosz-Pokorska A; Pięta M; Kędzia J; Janecki T; Janecka A
BMC Pharmacol Toxicol; 2020 Mar; 21(1):18. PubMed ID: 32122395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]